Meeting
2023 ASCO Gastrointestinal Cancers Symposium
The prognostic value of C-reactive protein/albumin ratio and platelet-lymphocyte ratio in patients with pancreatic cancer.
Authors
Yang-Chen Shen
Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan;
Yang-Chen Shen , Chi-Hsiang Chu , Po-See Chen , Cheng-Feng Lin , Ping-Yen Liu , Peng-Chan Lin , Chia-Jui Yen , Yan-Shen Shan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 678)
DOI
10.1200/JCO.2023.41.4_suppl.678
Abstract #
678
Poster Bd #
J3
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Nutritional impact and prognostic role of systemic inflammatory response index (SIRI) in advanced pancreatic cancer: PANTHEIA-Spanish Society of Medical Oncology (SEOM) study results.
First Author: Vilma Pacheco-Barcia
Poster
2020 ASCO Virtual Scientific Program
Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma.
First Author: Lucy Xiaolu Ma
Poster
2020 Gastrointestinal Cancers Symposium
Prognostic utility of inflammation biomarkers in a PDAC trial involving the human anti-CTGF antibody pamrevlumab.
First Author: Mark D. Sternlicht
Poster
2018 Gastrointestinal Cancers Symposium
Neutrophil-to-lymphocyte ratio as a prognostic marker for metastatic pancreatic cancer.
First Author: Jasmin Radhika Desai